Empirical Finance’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $674K | Buy |
7,387
+46
| +0.6% | +$4.2K | 0.04% | 375 |
|
|
2025
Q1 | $831K | Buy |
7,341
+239
| +3% | +$27.1K | 0.05% | 309 |
|
|
2024
Q4 | $750K | Sell |
7,102
-78
| -1% | -$8.24K | 0.04% | 327 |
|
|
2024
Q3 | $775K | Buy |
7,180
+156
| +2% | +$16.8K | 0.05% | 323 |
|
|
2024
Q2 | $762K | Sell |
7,024
-487
| -6% | -$52.9K | 0.05% | 316 |
|
|
2024
Q1 | $991K | Buy |
7,511
+255
| +4% | +$33.7K | 0.06% | 278 |
|
|
2023
Q4 | $883K | Buy |
7,256
+59
| +0.8% | +$7.18K | 0.06% | 281 |
|
|
2023
Q3 | $808K | Buy |
7,197
+659
| +10% | +$74K | 0.06% | 280 |
|
|
2023
Q2 | $952K | Buy |
6,538
+729
| +13% | +$106K | 0.07% | 246 |
|
|
2023
Q1 | $751K | Buy |
5,809
+321
| +6% | +$41.5K | 0.07% | 270 |
|
|
2022
Q4 | $700K | Buy |
5,488
+436
| +9% | +$55.6K | 0.07% | 269 |
|
|
2022
Q3 | $528K | Buy |
5,052
+835
| +20% | +$87.3K | 0.06% | 288 |
|
|
2022
Q2 | $443K | Buy |
4,217
+228
| +6% | +$24K | 0.06% | 300 |
|
|
2022
Q1 | $510K | Buy |
3,989
+325
| +9% | +$41.6K | 0.06% | 303 |
|
|
2021
Q4 | $452K | Buy |
3,664
+989
| +37% | +$122K | 0.05% | 327 |
|
|
2021
Q3 | $380K | Buy |
2,675
+154
| +6% | +$21.9K | 0.06% | 307 |
|
|
2021
Q2 | $394K | Buy |
2,521
+360
| +17% | +$56.3K | 0.06% | 283 |
|
|
2021
Q1 | $323K | Hold |
2,161
| – | – | 0.06% | 252 |
|
|
2020
Q4 | $323K | Buy |
2,161
+381
| +21% | +$56.9K | 0.06% | 252 |
|
|
2020
Q3 | $235K | Buy |
+1,780
| New | +$235K | 0.05% | 252 |
|
|
2017
Q1 | – | Sell |
-76
| Closed | -$8K | – | 592 |
|
|
2016
Q4 | $8K | Buy |
+76
| New | +$8K | 0.01% | 440 |
|